Intrinsiqq
Recordati Industria Chimica e Farmaceutica S.p.A. logo

Recordati Industria Chimica e Farmaceutica S.p.A. Quality Score

REC.XMIL

Compare
Quality68

Valuation remains strong (avg 80/100), but growth is pulling the composite down (avg 70/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
80/100
22.3x

20–25x range, moderate premium

Cash Flow Multiple
80/100
21.2x

20–25x, moderate cash flow premium

Revenue Growth
70/100
9.9%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
70/100
9.4%

5–10% CAGR, steady but not exceptional

Business Quality & Capital Allocation

Share Dilution
60/100
1.7%

Mild dilution under 2%

Margin Trend
100/100
+3.2pp

Expanded 3+pp, strong improvement

Return on Capital
60/100
12.6%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.XMIL) quality: score, margins and returns

Recordati Industria Chimica e Farmaceutica S.p.A. (REC.XMIL) scores 68/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 7 metrics each scored 0 to 100, on 29.9% operating margins and 12.6% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Recordati Industria Chimica e Farmaceutica S.p.A. (REC.XMIL) a high-quality business?+

Recordati Industria Chimica e Farmaceutica S.p.A. scores 68 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 29.9% operating margin and a 12.6% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Recordati Industria Chimica e Farmaceutica S.p.A.'s quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from REC.XMIL's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Recordati Industria Chimica e Farmaceutica S.p.A. scores well and where it falls behind.

What is Recordati Industria Chimica e Farmaceutica S.p.A.'s return on invested capital (ROIC)?+

Recordati Industria Chimica e Farmaceutica S.p.A. earns about 12.6% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to REC.XMIL's margins and growth on this scorecard to judge durability.

How profitable is Recordati Industria Chimica e Farmaceutica S.p.A.?+

Recordati Industria Chimica e Farmaceutica S.p.A. runs an operating margin of about 29.9% and a net margin of about 18.4%. Revenue has grown at roughly 13.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Drug Manufacturers - General · Pick stocks to compare with REC.XMIL

CompareIntrinsic value
AMP.XMILAmplifon SpA
€11.18-1.24%27
SFL.XMILSafilo Group S.p.A.
€2.06-6.78%69
ELN.XMILEL.En. S.p.A.
€16.12-2.01%53
GHC.XMILGarofalo Health Care S.p.A.
€5.08+0.00%40
PHIL.XMILPhilogen S.p.A.
€20.05+2.93%98
BNTXBioNTech SE
$80.96-0.52%16
GUBRA.XCSEGubra A/S
€34.90-2.73%98
SECARE.XSTOSwedencare AB
€1.71-3.17%61

Held by ETFs

REC.XMIL is in 70 US ETFs. The largest of them, with REC.XMIL's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing REC.XMIL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.